Articoli con mandati relativi all'accesso pubblico - Cornelia Lass-FlörlUlteriori informazioni
Non disponibili pubblicamente: 21
Antifungal drug resistance among Candida species: mechanisms and clinical impact
M Sanguinetti, B Posteraro, C Lass‐Flörl
Mycoses 58, 2-13, 2015
Mandati: Austrian Science Fund
Triazole antifungal agents in invasive fungal infections: a comparative review
C Lass-Flörl
Drugs 71, 2405-2419, 2011
Mandati: Austrian Science Fund
Laboratory diagnosis of mucormycosis: current status and future perspectives
M Lackner, R Caramalho, C Lass-Flörl
Future microbiology 9 (5), 683-695, 2014
Mandati: Austrian Science Fund
Breakpoints for antifungal agents: an update from EUCAST focussing on echinocandins against Candida spp. and triazoles against Aspergillus spp.
MC Arendrup, M Cuenca-Estrella, C Lass-Flörl, WW Hope
Drug Resistance Updates 16 (6), 81-95, 2013
Mandati: US National Institutes of Health, Austrian Science Fund, Government of Spain
Galleria mellonella: An invertebrate model to study pathogenicity in correctly defined fungal species
U Binder, E Maurer, C Lass-Flörl
Fungal Biology 120 (2), 288-295, 2016
Mandati: Austrian Science Fund
Bronchoalveolar lavage lateral-flow device test for invasive pulmonary aspergillosis in solid organ transplant patients: a semiprospective multicenter study
B Willinger, M Lackner, C Lass-Flörl, J Prattes, V Posch, B Selitsch, ...
Transplantation 98 (8), 898-902, 2014
Mandati: Austrian Science Fund
Bronchoalveolar lavage fluid (1, 3) β-D-glucan for the diagnosis of invasive fungal infections in solid organ transplantation: a prospective multicenter study
W Mutschlechner, B Risslegger, B Willinger, M Hoenigl, B Bucher, ...
Transplantation 99 (9), e140-e144, 2015
Mandati: Austrian Science Fund
Primary antifungal prophylaxis with micafungin in patients with haematological malignancies: real‐life data from a retrospective single‐centre observational study
D Nachbaur, O Angelova, D Orth‐Höller, A Ditlbacher, M Lackner, ...
European journal of haematology 94 (3), 258-264, 2015
Mandati: Austrian Science Fund
EUCAST Technical Note on Candida and micafungin, anidulafungin and fluconazole
M Cavling Arendrup, M Cuenca‐Estrella, C Lass‐Flörl, WW Hope, ...
Mycoses 57 (6), 377-379, 2014
Mandati: US National Institutes of Health, National Institute for Health Research, UK …
Amphotericin B Resistance in Aspergillus terreus Is Overpowered by Coapplication of Pro-oxidants
M Blatzer, E Jukic, W Posch, B Schöpf, U Binder, M Steger, G Blum, ...
Antioxidants & redox signaling 23 (18), 1424-1438, 2015
Mandati: Austrian Science Fund
Up-date on diagnostic strategies of invasive aspergillosis
M Lackner, C Lass-Florl
Current pharmaceutical design 19 (20), 3595-3614, 2013
Mandati: Austrian Science Fund
Antifungal susceptibility profiles of rare ascomycetous yeasts
A Pérez-Hansen, C Lass-Flörl, M Lackner
Journal of Antimicrobial Chemotherapy 74 (9), 2649-2656, 2019
Mandati: Austrian Science Fund, European Commission, Government of Spain
Perspectives on Scedosporium species and Lomentospora prolificans in lung transplantation: Results of an international practice survey from ESCMID fungal …
B Rammaert, M Puyade, OA Cornely, D Seidel, P Grossi, S Husain, ...
Transplant infectious disease 21 (5), e13141, 2019
Mandati: UK Medical Research Council
Invasive candidiasis: future directions in non-culture based diagnosis
W Posch, D Heimdörfer, D Wilflingseder, C Lass-Flörl
Expert Review of Anti-infective Therapy 15 (9), 829-838, 2017
Mandati: Austrian Science Fund, European Commission
Elevated minimum inhibitory concentrations to antifungal drugs prevail in 14 rare species of candidemia-causing Saccharomycotina yeasts
AA Stavrou, A Pérez-Hansen, M Lackner, C Lass-Flörl, T Boekhout
Medical Mycology 58 (7), 987-995, 2020
Mandati: Austrian Science Fund, European Commission
Current issues in the clinical management of invasive candida infections–the AGIHO, DMykG, ÖGMM and PEG web‐based survey and expert consensus conference 2009
M Karthaus, M Rüping, OA Cornely, A Steinbach, AH Groll, C Lass‐Flörl, ...
Mycoses 54 (5), e546-e556, 2011
Mandati: German Research Foundation
In vitro susceptibility testing in fungi: what is its role in clinical practice?
S Perkhofer, C Mrazek, L Hartl, C Lass-Flörl
Current infectious disease reports 12, 401-408, 2010
Mandati: Austrian Science Fund
Azole-resistant and -susceptible Aspergillus fumigatus isolates show comparable fitness and azole treatment outcome in immunocompetent mice
M Lackner, G Rambach, E Jukic, B Sartori, J Fritz, C Seger, M Hagleitner, ...
Medical mycology 56 (6), 703-710, 2018
Mandati: Austrian Science Fund
Multidrug- and Cross-Resistant Candida: the Looming Threat
M Lackner, A Martin-Vicente, C Lass-Flörl
Current Fungal Infection Reports 9, 23-36, 2015
Mandati: Austrian Science Fund
Current issues in the clinical management of invasive aspergillosis–the AGIHO, DMykG, ÖGMM and PEG web‐based survey and expert consensus conference 2009
M Rüping, JJ Vehreschild, A Groll, C Lass‐Flörl, H Ostermann, M Ruhnke, ...
Mycoses 54 (5), e557-e568, 2011
Mandati: German Research Foundation
Le informazioni sulla pubblicazione e sul finanziamento vengono stabilite automaticamente da un software